34.1 C
New York
Thursday, June 11, 2026

Tag: surgeons

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum

GRAND RAPIDS, Mich., June 11, 2025 /PRNewswire/ -- cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company,...

Safe Group announces FDA 510(k) clearance for SpineUp’s Frida solution

Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution

LeanTaaS Launches iQueue for Surgical Clinics, Delivering the Industry’s First End‑to‑End Surgical Coordination Platform

Unveiled live at Transform, LeanTaaS' hospital operations summit, the new product embeds key case building, managing, and scheduling capabilities integrated with clinic EHRs to drive...

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO™ Sacroiliac (SI) Joint Fusion System has been successfully used in over 2,500 procedures across the United States. This major milestone underscores the company’s accelerating growth and increasing adoption of its minimally invasive technology by surgeons nationwide.

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

AirSculpt Announces Public Offering of Common Stock

MIAMI BEACH, Fla., June 09, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the launch of an underwritten public offering of 3,160,000 shares of its common stock. The underwriter will also have a 30-day option to purchase up to 474,000 additional shares of common stock. All of the shares of common stock in the offering are being sold by the Company.

New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1

Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of...

AOFAS Awards More Than $258,000 in Grants to Fund Foot and Ankle Orthopaedic Research

SCHAUMBURG, Ill., June 6, 2025 /PRNewswire/ -- The American Orthopaedic Foot & Ankle Society (AOFAS) awarded its annual research grants to 12 promising foot and...

Nuvia’s Chief Clinical Officer, Dr. Preston Hansen, Featured as May Cover Story in CXO Magazine

SALT LAKE CITY, June 6, 2025 /PRNewswire/ -- Nuvia Dental Implant Center's Chief Clinical Officer, Dr. Preston Hansen, has been featured as the May...

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grant of an option to purchase 75,000 shares of its common stock and restricted stock units covering 30,000 shares of its common stock to Jim Hagen, the Company’s Senior Vice President – Strategic Commercial Operations, with a grant date of June 2, 2025 (the "Grant Date"). The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of Mr. Hagen’s employment compensation and were granted as an inducement material to his acceptance of employment with TELA Bio.

- A word from our sponsors -

spot_img
HomeTagsSurgeons